Specificity (tests)

Jump to navigation Jump to search

WikiDoc Resources for Specificity (tests)

Articles

Most recent articles on Specificity (tests)

Most cited articles on Specificity (tests)

Review articles on Specificity (tests)

Articles on Specificity (tests) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Specificity (tests)

Images of Specificity (tests)

Photos of Specificity (tests)

Podcasts & MP3s on Specificity (tests)

Videos on Specificity (tests)

Evidence Based Medicine

Cochrane Collaboration on Specificity (tests)

Bandolier on Specificity (tests)

TRIP on Specificity (tests)

Clinical Trials

Ongoing Trials on Specificity (tests) at Clinical Trials.gov

Trial results on Specificity (tests)

Clinical Trials on Specificity (tests) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Specificity (tests)

NICE Guidance on Specificity (tests)

NHS PRODIGY Guidance

FDA on Specificity (tests)

CDC on Specificity (tests)

Books

Books on Specificity (tests)

News

Specificity (tests) in the news

Be alerted to news on Specificity (tests)

News trends on Specificity (tests)

Commentary

Blogs on Specificity (tests)

Definitions

Definitions of Specificity (tests)

Patient Resources / Community

Patient resources on Specificity (tests)

Discussion groups on Specificity (tests)

Patient Handouts on Specificity (tests)

Directions to Hospitals Treating Specificity (tests)

Risk calculators and risk factors for Specificity (tests)

Healthcare Provider Resources

Symptoms of Specificity (tests)

Causes & Risk Factors for Specificity (tests)

Diagnostic studies for Specificity (tests)

Treatment of Specificity (tests)

Continuing Medical Education (CME)

CME Programs on Specificity (tests)

International

Specificity (tests) en Espanol

Specificity (tests) en Francais

Business

Specificity (tests) in the Marketplace

Patents on Specificity (tests)

Experimental / Informatics

List of terms related to Specificity (tests)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S.

Overview

The specificity is a statistical measure of how well a binary classification test correctly identifies the negative cases. It is the probability that a test correctly classifies individuals without preclinical disease as negative. It is a proportional measurement and is often expressed in terms of percentage.

Calculation

For example, given a medical test that determines if a person has a certain disease, the specificity of the test to the disease is the probability that the test indicates `negative' if the person does not have the disease.

That is, the specificity is the proportion of true negatives of all negative cases in the population. It is a parameter of the test.

High specificity is important when the treatment or diagnosis is harmful to the patient mentally and/or physically.[1]

Worked example

Template:SensSpecPPVNPV

Definition

<math>{\rm specificity}=\frac{\rm number\ of\ True\ Negatives}{{\rm number\ of\ True\ Negatives}+{\rm number\ of\ False\ Positives}}</math>

A specificity of 100% means that the test recognizes all healthy people as healthy. The maximum is trivially achieved by a test that claims everybody healthy regardless of the true condition. Therefore, the specificity alone does not tell us how well the test recognizes positive cases. We also need to know the sensitivity of the test to the class, or equivalently, the specificities to the other classes.[1]


A test with a high specificity has a low Type I error rate.

Specificity is sometimes confused with the precision or the positive predictive value, both of which refer to the fraction of returned positives that are true positives. The distinction is critical when the classes are different sizes. A test with very high specificity can have very low precision if there are far more true negatives than true positives, and vice versa.<[1]


SPPIN and SNNOUT

SPPIN SNNOUT Neither Near-perfect
Proposed definition Sp > 95% SN > 95% Both < 95% Both > 99%
Example Many physical dx findings Ottawa fracture rules[2] Exercise treadmill test[3] HIV-1/HIV-2 4th gen test[4]
Predictive values:
10% pretest prob PPV= 35%

NPV = 99%

PPV = 64%

NPV = 98%

PPV = 31%

NPV = 97%

PPV = 92%

NPV > 99%

50% pretest prob PPV = 94%

NPV = 83%

PPV = 83%

NPV = 94%

PPV = 80%

NPV = 80%

PPV = 99%

NPV = 99%

90% pretest prob PPV = 98%

NPV = 64%

PPV = 99%

NPV = 35%

PPV = 97%

NPV = 31%

PPV > 99%

NPV = 92%

Clinical messages Accept test result when:
  1. confirms your suspicion
  2. maybe when pretest was a toss-up
Accept test result when:
  1. confirms a strong suspicion
Accept test result unless:
  1. Contradicts a strong suspicion
Notes:

Green font indicates when results are more likely to be trustable
Red font indicates SPPIN/SNNOUT errors when you should be suspicous a a SPPIN/SNNOUT result

Related Chapters

Online Calculators

References

  1. 1.0 1.1 1.2 Altman DG, Bland JM (1994). "Diagnostic tests. 1: Sensitivity and specificity". BMJ. 308 (6943): 1552. PMID 8019315.
  2. Stiell, Ian. "The Ottawa Rules". University of Ottawa. Retrieved January 5, 2020.
  3. Banerjee A, Newman DR, Van den Bruel A, Heneghan C (2012). "Diagnostic accuracy of exercise stress testing for coronary artery disease: a systematic review and meta-analysis of prospective studies". Int J Clin Pract. 66 (5): 477–92. doi:10.1111/j.1742-1241.2012.02900.x. PMID 22512607. Note that 80% is a rough estimate of sensitivity and specificity.
  4. Malloch L, Kadivar K, Putz J, Levett PN, Tang J, Hatchette TF; et al. (2013). "Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I". J Clin Virol. 58 Suppl 1: e85–91. doi:10.1016/j.jcv.2013.08.008. PMID 24342484.

External links

su:Spésifisitas


Template:WikiDoc Sources